Academy Project funding for Professor Mauri Kostiainen
Professor Mauri Kostiainen receives Consortium Project funding from the Academy of Finland
The SEMMA consortium aims to develop technologies for capturing human proteins directly from cell lines for their structure determination. These methods will be used to study several targets involved in human protein homeostasis, a control mechanism in every living cell. These novel technologies are expected to be widely applicable in studying basic biomolecular mechanisms and disease and offer potential for commercialization. SEMMA is a consortium between Prof. Kostiainen, head of the Biohybrid Materials Research Group at Aalto University, and project PI Prof. Juha T. Huiskonen and Dr. Ville Paavilainen at the University of Helsinki.
Read more news
The State of Marketing survey: Performance monitoring and budgeting remain relatively weak
Markkinoinnin tila (The State of Marketing) survey opens up important perspectives to the Finnish marketing knowhow and areas for development in marketing
What is quantum tech?
Many of today’s devices would not exist without quantum technology, but the most exciting applications are still on the horizon
Is quantum the next AI? Behind the quantum hype
Doctoral researcher Christa Schauman explains how Finland and Europe are faring in a race everyone wants to join – despite its uncertainties.